Company intelligence / Profile preview

Fund+

Groot Begijnhof of Leuven, Belgiumfundplus.be ↗

Ownership: Private
Development stage: Other

Overview

Fund+ is a Belgian-based open-ended investment fund focused on long-term equity investments in innovative life sciences companies. It primarily invests in therapeutics as well as diagnostics and medical device companies that have achieved proof of concept. The fund aims for both financial returns and societal impact by supporting the biotech ecosystem in Belgium

Therapeutic areas: Other
Modalities: Not applicable (Fund+ is an investor/fund and does not directly develop therapeutic modalities)
Industry: Investors

Partnerships

Co-investments with Omega FundsLSP Life Sciences Partnersothers via syndicate deals

Beyond the preview

Go deeper on Fund+.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fund+.

Explore the full profile